Modern Diagnostic's Initial Public Offering (IPO) saw strong investor demand, being subscribed over 350 times by its closing date. The grey market premium (GMP) indicated a potential listing gain of 15-18 percent. The company plans to utilize IPO proceeds for purchasing medical equipment, funding working capital, repaying borrowings, and general corporate purposes, including expansion and opening new centers.